Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1204581626 | 12045816 | 26 | F | 20160119 | 20160721 | 20160208 | 20160722 | EXP | CA-ROCHE-1707409 | ROCHE | 64.22 | YR | F | Y | 0.00000 | 20160722 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1204581626 | 12045816 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2048,B2058,B2060,B2050,B2052,B2061 | 125276 | 600 | MG | SOLUTION FOR INFUSION | |||||||
| 1204581626 | 12045816 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2048,B2058,B2060,B2050,B2052,B2061 | 125276 | 300 | MG | SOLUTION FOR INFUSION | |||||||
| 1204581626 | 12045816 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B2048,B2058,B2060,B2050,B2052,B2061 | 125276 | 600 | MG | SOLUTION FOR INFUSION | |||||||
| 1204581626 | 12045816 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 1204581626 | 12045816 | 5 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 1204581626 | 12045816 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 1204581626 | 12045816 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 1204581626 | 12045816 | 8 | C | SIMPONI | GOLIMUMAB | 1 | 0 | ||||||||||||
| 1204581626 | 12045816 | 9 | C | BETADERM (CANADA) | 2 | 0 | |||||||||||||
| 1204581626 | 12045816 | 10 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | 0 | ||||||||||||
| 1204581626 | 12045816 | 11 | C | CEFADROXIL. | CEFADROXIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1204581626 | 12045816 | 1 | Rheumatoid arthritis |
| 1204581626 | 12045816 | 4 | Product used for unknown indication |
| 1204581626 | 12045816 | 5 | Arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1204581626 | 12045816 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1204581626 | 12045816 | Abdominal pain lower | |
| 1204581626 | 12045816 | Acne | |
| 1204581626 | 12045816 | Arthralgia | |
| 1204581626 | 12045816 | Cataract | |
| 1204581626 | 12045816 | Chest pain | |
| 1204581626 | 12045816 | Dermatitis contact | |
| 1204581626 | 12045816 | Diarrhoea | |
| 1204581626 | 12045816 | Drug ineffective | |
| 1204581626 | 12045816 | Dry skin | |
| 1204581626 | 12045816 | Erythema | |
| 1204581626 | 12045816 | Fatigue | |
| 1204581626 | 12045816 | Haemorrhoids | |
| 1204581626 | 12045816 | Joint effusion | |
| 1204581626 | 12045816 | Laceration | |
| 1204581626 | 12045816 | Madarosis | |
| 1204581626 | 12045816 | Malaise | |
| 1204581626 | 12045816 | Myalgia | |
| 1204581626 | 12045816 | Nocturia | |
| 1204581626 | 12045816 | Oropharyngeal pain | |
| 1204581626 | 12045816 | Oxygen saturation decreased | |
| 1204581626 | 12045816 | Pain | |
| 1204581626 | 12045816 | Pain in extremity | |
| 1204581626 | 12045816 | Peripheral swelling | |
| 1204581626 | 12045816 | Plantar erythema | |
| 1204581626 | 12045816 | Pruritus | |
| 1204581626 | 12045816 | Pyrexia | |
| 1204581626 | 12045816 | Rash erythematous | |
| 1204581626 | 12045816 | Sinusitis | |
| 1204581626 | 12045816 | Skin atrophy | |
| 1204581626 | 12045816 | Skin exfoliation | |
| 1204581626 | 12045816 | Vaginal infection | |
| 1204581626 | 12045816 | Vulvovaginal mycotic infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1204581626 | 12045816 | 1 | 20160119 | 0 | ||
| 1204581626 | 12045816 | 2 | 20160401 | 0 | ||
| 1204581626 | 12045816 | 3 | 20160428 | 20160630 | 0 |